OCUNEXUS THERAPEUTICS
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology. The company specializes in developing highly differentiated drug candidates based upon a novel mechanism of action called “Gap Junction Channel Modulation.” It has developed treatments for multiple front- and back-of-the-eye diseases and disorders that would potentially alter the standard of care. In addition, the company's technologies are expected to be transferable to other acute and chronic disease indications. Ocunexus is formerly known as CoDa Therapeutics, a pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. The company is based in San Diego, California.
OCUNEXUS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ocunexus.com
Total Employee:
1+
Status:
Closed
Contact:
(858) 677-0474
Email Addresses:
[email protected]
Total Funding:
78.59 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioPacific Ventures
BioPacific Ventures investment in Series B - Ocunexus Therapeutics
RMI Partners
RMI Partners investment in Series B - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series B - Ocunexus Therapeutics
Square 1 Bank
Square 1 Bank investment in Debt Financing - Ocunexus Therapeutics
BioPacific Ventures
BioPacific Ventures investment in Series B - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series A - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series A - Ocunexus Therapeutics
Official Site Inspections
http://www.ocunexus.com
- Host name: 156.241.168.251
- IP address: 156.241.168.251
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
More informations about "Ocunexus Therapeutics"
CuneXus - Crunchbase Company Profile & Funding
Jun 19, 2013 CuneXus may be growing as evidenced by its acquisition by TruStage, formerly known as CUNA Mutual Group, in 2020, which is a significant corporate development …See details»
TruStage™ renames CuneXus, Digital Storefront and …
Sep 26, 2023 MADISON, Wis. — Today, TruStage announced CuneXus will be known as ‘Digital Storefront’. The new name reflects the fintech’s evolution since it was acquired by TruStage in 2020 and aligns with the organization’s rebrand …See details»
Digital Storefront Company Profile 2024: Valuation, Investors ...
Digital Storefront General Information Description. Developer of a lending automation platform intended to help credit unions and banks drive significant loan volume across all product …See details»
CUneXus - CUInsight
CuneXus client institutions represent over $596 billion in combined assets and 30 million U.S. consumers, funding $60-$70 million in loans daily. For more information, visit …See details»
CuneXus | Your Guide to the Digital Storefront
Discover how financial institutions across the country are using CuneXus to deliver 1-click, perpetual loans to their members and customers. Read how our partners like First American Bank expanded their lending opportunities , how …See details»
Ocunexus Therapeutics - Crunchbase Company Profile & Funding
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology. The company specializes in developing highly differentiated …See details»
Origence, CuneXus Partnership Gives Credit Unions Access to …
Aug 3, 2021 About CuneXus CuneXus, is the first-to-market with a digital storefront for financial institution’s customers and members, addressing the need for a personalized, on-demand …See details»
CuneXus | News & Awards
Our team values your time and strives to bring the CuneXus digital storefront to vivid life with a demo that speaks to your financial institution’s unique needs, challenges and opportunities. Ready to learn more? Get in touch. Contact. …See details»
OcuNexus - VentureRadar
Similar Companies: InflammX Therapeutics USA Privately Held InflammX Therapeutics has highly differentiated, lead drug candidates based upon a novel mechanism of action called “Gap …See details»
CuneXus and Equifax Team Up to Offer Lenders Premium Financial …
Dec 16, 2021 SANTA ROSA, Calif. and ATLANTA, Dec. 16, 2021 /PRNewswire/ -- CuneXus and Equifax (NYSE: EFX) today have teamed up to offer CuneXus credit union customers a …See details»
Contact - CuneXus
Our team values your time and strives to bring the CuneXus digital storefront to vivid life with a demo that speaks to your financial institution’s unique needs, challenges and opportunities. …See details»
Ocunexus Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ocunexus Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Origence, CuneXus partnership gives credit unions access to …
Aug 3, 2021 CuneXus client institutions represent over $596 billion in combined assets and 30 million U.S. consumers, funding $60-$70 million in loans daily. For more information, visit …See details»
Ocunexus Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Ocunexus Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
CuneXus and Experian Offer Optimized Consumer Lending …
Aug 4, 2022 CuneXus client institutions represent over $596 billion in combined assets and 30 million U.S. consumers, funding $60-$70 million in loans daily. For more information, visit …See details»
Ocunexus Therapeutics - Contacts, Employees, Board Members, …
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.See details»
CuneXus Enters into Financial Wellness Market with a New Credit ...
Nov 29, 2021 The new addition to the CuneXus technology provides financial institutions’ account holders with a more consistent and seamless digital experience by displaying their …See details»
CuneXus | How To Cross-Sell Non-Interest Income Offers
With the CuneXus digital storefront, these institutions can identify where to integrate non-interest income products for a more streamlined lending operation. As one example, FirstLight Federal …See details»
Proactive, personalized loans boost financial wellness and
Aug 3, 2021 Proactive, personalized loans boost financial wellness and drive retention. Santa Rosa, Calif. – August 3, 2021 – CuneXus, the first and only digital storefront for financial …See details»
CuneXus | One-Click Consumer Acquisition Strategy
But with the CuneXus digital storefront, financial institutions can now activate pre-screened lending technology to target both current account holders and acquire new members and …See details»